Abstract:OBJECTIVE:To evaluate the inhibition of CD4+ CD25+ regulatory T cells (Treg) in the chronic hepatitis B patients.METHODS:Peripheral blood samples were collected from 22 patients with chronic hepatitis B (CHB) and 18 healthy blood donors to isolate the peripheral blood mononuclear cells (PBMCs). Flow cytometry was used to analyze the proportion of CD4+ CD127(lo)CD25(hi-int) Tregs in the CD4+ T cells so as to calculate the proportion of CD4+ CD25+ Tregs in the CD4+ T cells. BrdU incorporation method was used to evaluate the immune inhibition of the CD4+ CD25+ Tregs. CD4+ CD25- cells were isolated by magnetic bead sorting technique. The CD4- T cells and CD4+ CD25- T cells ere mixed and stimulated by HBVcore 18-27 peptide. The PBMCs of the CHB patients with the Treg depleted and Treg not depleted underwent detection of HBVcore18-27 specific cytotoxic T lymphocytes (CTLs). The IFN-gamma secretion of the CTLs in the PBMCs of CHB patients with Treg depleted and Treg not depleted was detected by HLA-pentamer and enzyme-linked immunospot assay (Elispot).RESULTS:The proportion of CD4+ CD127(lo)CD25(hi-int) Treg in the CD4+ T cells used to reflect the percentage of CD4+CD25+ Tregs in the CD4+ T cells of the CHB patients was 4.3% +/- 2.4%, significantly higher than that of the healthy controls (2.1% +/- 1.3%, t = 3.74, P <0.01). There was no significant difference in the inhibition of CD4+ CD25- T cells by autogenous CD4+ CD25+ T cells between the CHB patients and healthy controls. The frequency of CTLs induced by HBV core 18-27 of the CHB patients with their CD4+ CD25+ cells in circulation depleted was 0.74% +/- 0.31%, significantly higher than that of the patients whose CD4+ CD25+ cells in circulation were not depleted (0.17% +/- 0.08%, t = 4.75, P <0.01). The frequency of IFN-gamma secreting spots of HBVcore18-27-specific CD8+ T cells of the CHB patients with their CD4+ CD25+ cells depleted was (112 +/- 33), significantly higher than that of the CHB patients whose CD4+ CD25+ cells in circulation were not depleted [(23 +/- 14), t =7.828, P<0.01)].CONCLUSION:The proportion of CD4+ CD25+ Treg in CHB patients is increased compared to the healthy blood donor. The proliferative capacity of CD4+ CD25- T cells is inhibited by the presence of CD4+ CD25+ Treg dose-dependently, and the inhibition of CD4+ CD25+ Tregs in the CHB patients is similar to the inhibition of CD4+ CD25+ Tregs in healthy donors. The elimination of Treg cells followed by stimulation with HBVcore18-27 peptide significantly improves the antivirus CTL responses in CHB patients.

CD_(25) Expression in Peripheral Blood T Lymphocytes from Patients with Chronic Hepatitis B and Its Significance

Clinical Significance and Detection of IL-18 in the Chronic Patients with HBV Infection

Analysis of the CD4 + CD25 high regulatory T cells in peripheral blood of chronic hepatitis B virus infected patients

The role of CD4+C D25+ regulatory T cells in the pathogenesis of severe hepatitis B

Expression Levels of CD4~+CD25~+ Regulatory T Cells in Peripheral Blood of Patients with Chronic Hepatitis B and Clinical Significance

CTLA4 Expression in Peripheral Blood T Lymphocytes of Patients with Chronic Hepatitis B and Its Significance

The function of circulating CD4+CD25+ regulatory T cells in patients with chronic hepatitis B

The research of CD4+CD25+Treg and partial cytokines from patients with chronic hepatitis B

Research on expression of four important molecules of CD4+CD25+ regulatory T cells In hepatitis B patients

The role of CD4+CD25+Foxp3 regulatory T cells in patients with chronic hepatitis B

HBV genotype and CD_4~+CD_(25)~+ regulatory T cell expression and chronic hepatitis B clinical manifestation

Expressions of CD45RA and CD27 by T Lymphocytes from PBMC of Patients with Chronic Hepatitis B

CD4 + CD25 + regulatory T-cells: a potential target for treating patients with chronic HBV infection

Phenotypes and clinical significance of circulating CD4 + CD25 + regulatory T cells (Tregs) in patients with acute-on-chronic liver failure (ACLF)

CD8+ T Cell Immune Response in Peripheral Blood of Patients with Chronic HBV Infection

The role of liver-targeted CD4+ CD25+ Foxp3+ regulatory T cells in the patients with chronic hepatitis B

Inhibition of CD4+ CD25+ Regulatory T Cells in Chronic Hepatitis B Patients

Circulating Cd4(+) Cd25(+) Regulatory T Cells Correlate With Chronic Hepatitis B Infection

Distributional Characteristics of Cd25 and Cd127 on Cd4+ T Cell Subsets in Chronic Hcv Infection

[Detection of HBV Specific Cytotoxic Lymphocytes Responses in Severe Hepatitis B Patients Using MHC-peptide Tetramer Flow Cytometry].

Association Of Cd4(+)Cd25(+)Foxp3(+) Regulatory T Cells With Chronic Activity And Viral Clearance In Patients With Hepatitis B